Company Snapshot: SCIO  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Scios Announces Webcast of Presentation at the BIO CEO & Investor Conference 2003

    SUNNYVALE, Calif., Feb. 25 /PRNewswire-FirstCall/ --
Scios Inc. (Nasdaq: SCIO) today announced that Richard B. Brewer, president
and chief executive officer, will present at the BIO CEO & Investor Conference
2003 on Wednesday, February 26th, 2003, at 11:30 a.m. EST at the Waldorf
Astoria Hotel in New York City.
    Mr. Brewer's presentation will be simultaneously broadcast over the
Internet and will be available to members of the news media, investors and the
general public. The presentation is expected to last approximately 30 minutes.
Viewers are encouraged to visit the website at least fifteen minutes prior to
the beginning of the scheduled presentation to register, download and install
all necessary audio software.
    This event can be accessed at the Scios website, http://www.sciosinc.com, and
will be archived for replay for 7 days after the conference.

    Scios Inc.
    Scios is a biopharmaceutical company developing novel treatments for
cardiovascular and inflammatory disease. The Company's disease-based
technology platform integrates expertise in protein biology with computational
and medicinal chemistry to identify novel targets and rationally design small
molecule compounds for large markets with unmet medical needs.


SOURCE Scios Inc.




Back to Topback to top

Related links:
  • http://www.sciosinc.com
    CONTACT:
    media and investors, Suzanne Beveridge of
    Scios Inc., +1-408-616-2947; media, Jim Weiss of WeissCom
    Partners, Inc., +1-415-260-1274, or investors, Fern Lazar or Sara
    Moorin of Lazar Partners Ltd., +1-212-867-1762, all for Scios